TrademarkDir
NOVOCLEAR
LIVE

Serial Number

98349052

Owner

Aventix Medical Inc.

Attorney

Christopher D. Olszyk, Jr.

Filing Date

Jan 9, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NOVOCLEAR Trademark

Serial Number: 98349052

NOVOCLEAR is a trademark filed by Aventix Medical Inc. on January 9, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Aventix Medical Inc. (2 trademarks)

15375 Barranca Parkway, Suite B-210
Irvine, CA 92618

Entity Type: 03

Trademark Details

Filing Date

January 9, 2024

Registration Date

Not Registered

Published for Opposition

December 16, 2025

Goods & Services

Surgical instruments for use in ENT surgery

Filing History

TEAS STATEMENT OF USE RECEIVED
Apr 10, 2026 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 10, 2026 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 3, 2026 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 3, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 3, 2026 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 10, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 14, 2025 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 10, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 9, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 9, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 7, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 7, 2024 GNSL
SUSPENSION LETTER WRITTEN
Aug 7, 2024 CNSL
ASSIGNED TO EXAMINER
Aug 5, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2024 NWOS
NEW APPLICATION ENTERED
Jan 9, 2024 NWAP

Related Trademarks

More from this Owner

AVENTIX

AVENTIX

AVENTIX

AVENTIX

AVENTIX

AVENTIX